CEL-SCI Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

26.03M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	-	-	-
Sep 30, 2024	-	-	-
Sep 30, 2023	-	-	-
Sep 30, 2022	-	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

CVM News

8 days ago - CEL-SCI reports Q3 EPS (47c) vs ($1.36) last year - TheFly
8 days ago - CEL-SCI Reports Fiscal Third Quarter 2026 Results - Business Wire
21 days ago - CEL-SCI announces publication of study supporting multikine biomarker strategy - TheFly
21 days ago - CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study - Business Wire
26 days ago - CEL-SCI announces manuscript on Phase 3 study to be published in Oral Oncology - TheFly
26 days ago - Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Business Wire
6 weeks ago - CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study - TheFly
6 weeks ago - CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer - Business Wire

More News